3.0.0
2707
2024-12-21T09:05:24Z
2024-12-21T09:05:24Z
House
H
HR
2023-04-19
118
[Congressional Record Volume 169, Number 65 (Wednesday, April 19, 2023)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. CARTER of Georgia:H.R. 2707.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8 of the ConstitutionThe single subject of this legislation is:To mitigate drug shortages and provide incentives formaintaining, expanding, and relocating the manufacturing ofactive pharmaceutical ingredients, excipients, medicaldiagnostic devices, pharmaceuticals, and personal protectiveequipment in the United States, and for other purposes.[Page H1887]
- hswm00
Ways and Means Committee
House
Standing
  - hswm02
Health Subcommittee
    - Referred to
2024-12-17T15:25:22Z
  - Referred to
2023-04-19T14:01:50Z
- 2024-12-17
  - hswm02
Health Subcommittee
1
House committee actions
Referred to the Subcommittee on Health.
Committee
- 2023-04-19
Referred to the House Committee on Ways and Means.
IntroReferral
H11100
2
House floor actions
  - hswm00
Ways and Means Committee
- 2023-04-19
Introduced in House
IntroReferral
Intro-H
9
Library of Congress
- 2023-04-19
Introduced in House
IntroReferral
1000
9
Library of Congress
- C001103
Rep. Carter, Earl L. "Buddy" [R-GA-1]
Earl
Carter
R
GA
L. "Buddy"
1
N
- S001200
Rep. Soto, Darren [D-FL-9]
Darren
Soto
D
FL
9
2023-04-19
True
- M001205
Rep. Miller, Carol D. [R-WV-1]
Carol
Miller
R
WV
D.
1
2023-04-19
True
- C001090
Rep. Cartwright, Matt [D-PA-8]
Matt
Cartwright
D
PA
8
2023-04-19
True
- H001067
Rep. Hudson, Richard [R-NC-9]
Richard
Hudson
R
NC
9
2023-04-19
True
- B001257
Rep. Bilirakis, Gus M. [R-FL-12]
Gus
Bilirakis
R
FL
M.
12
2023-04-19
True
- G000568
Rep. Griffith, H. Morgan [R-VA-9]
H.
Griffith
R
VA
Morgan
9
2023-04-19
True
- B001306
Rep. Balderson, Troy [R-OH-12]
Troy
Balderson
R
OH
12
2023-04-19
True
- V000133
Rep. Van Drew, Jefferson [R-NJ-2]
Jefferson
Van Drew
R
NJ
2
2023-04-19
True
- C001087
Rep. Crawford, Eric A. "Rick" [R-AR-1]
Eric
Crawford
R
AR
A. "Rick"
1
2023-04-19
True
- H001086
Rep. Harshbarger, Diana [R-TN-1]
Diana
Harshbarger
R
TN
1
2023-04-19
True
- L000600
Rep. Langworthy, Nicholas A. [R-NY-23]
Nicholas
Langworthy
R
NY
A.
23
2023-04-19
True
- J000304
Rep. Jackson, Ronny [R-TX-13]
Ronny
Jackson
R
TX
13
2023-05-23
False
- R000609
Rep. Rutherford, John H. [R-FL-5]
John
Rutherford
R
FL
H.
5
2024-01-17
False
Health
Health
2023-04-27T18:45:59Z
00
2023-04-19
Introduced in House
2023-11-29T18:52:27Z
Manufacturing API, Drugs, and Excipients in America Act or the MADE in America Act
This bill establishes a tax credit for certain manufacturers of pharmaceuticals or medical products.
Specifically, the bill establishes a tax credit for manufacturers of pharmaceuticals, active pharmaceutical ingredients, excipients (i.e., inactive ingredients), medical diagnostic devices, or personal protective equipment, if they are located in a designated distressed zone. The tax credit is equal to 25% of the manufacturer's production expenditures; the credit increases to 30% of expenditures if a substantial portion of the manufacturer's employees reside in a distressed zone.
The bill defines distressed zone as an area that has been designated as a qualified opportunity zone by the Internal Revenue Service (i.e., an economically distressed community in which certain new investments may be eligible for preferential tax treatment) and that has a poverty rate of over 30%.

MADE in America Act
- Display Title
45

MADE in America Act
2024-07-24T15:22:38Z
- Short Title(s) as Introduced
101

MADE in America Act
2024-05-24T13:40:48Z
Introduced in House
IH
- Short Title(s) as Introduced
101

Manufacturing API, Drugs, and Excipients in America Act
2024-05-24T13:40:48Z
Introduced in House
IH
- Official Title as Introduced
6

To mitigate drug shortages and provide incentives for maintaining, expanding, and relocating the manufacturing of active pharmaceutical ingredients, excipients, medical diagnostic devices, pharmaceuticals, and personal protective equipment in the United States, and for other purposes.
2024-03-18T20:38:40Z
Introduced in House
IH
- Introduced in House
2023-04-19T04:00:00Z
  - https://www.govinfo.gov/content/pkg/BILLS-118hr2707ih/xml/BILLS-118hr2707ih.xml
2024-12-17
Referred to the Subcommittee on Health.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.